C/M Capital Partners, Lp - 30 Jun 2025 SCHEDULE 13G/A Report for Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.000001 GBP per share (BDRX)

Filing Manager
C/M Capital Partners, Lp
Reporting Manager
Cavalry Fund I LP
Security
Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.000001 GBP per share
Symbol
BDRX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:18:12
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Cavalry Fund I LP 0% 0 0 0 /s/ Thomas Walsh By: Cavalry Fund I GP LLC, General Partner, By: Thomas Walsh, Manager
C/M CAPITAL PARTNERS, LP 0% 0 0 0 /s/ Thomas Walsh Thomas Walsh, Partner
Cavalry Investment Fund, LP 0% 0 0 0 /s/ Thomas Walsh By: Cavalry Fund GP, LLC, General Partner, By: Thomas Walsh, Managing Member
Cavalry Fund I Management LLC 0% 0 0 0 /s/ Thomas Walsh Thomas Walsh, Manager
Mercer Street Global Opportunity Fund, LLC 0% 0 0 0 /s/ Jonathan Juchno By: NFSO, LLC, its General Partner, By: Jonathan Juchno, Authorized Representative
Mercer Street Capital Partners, LLC 0% 0 0 0 /s/ Jonathan Juchno Jonathan Juchno, Authorized Representative
Thomas Walsh 0% 0 0 0 /s/ Thomas Walsh Thomas Walsh, Individually
Jonathan Juchno 0% 0 0 0 /s/ Jonathan Juchno Jonathan Juchno, Individually